Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FEMY

Femasys (FEMY)

Femasys Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FEMY
DateTimeSourceHeadlineSymbolCompany
2:09PMiHub NewswireFeaturedPOET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems
11:00AMiHub NewswireFeaturedElement79 Gold Corp Reports Exceptionally High-Grade Results from Lucero
05/09/20248:40AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FEMYFemasys Inc
05/09/20248:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
05/09/20248:30AMGlobeNewswire Inc.Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
05/07/20248:30AMGlobeNewswire Inc.Femasys Expands Commercial Management Team with Addition of Experienced New HiresNASDAQ:FEMYFemasys Inc
04/18/20248:30AMGlobeNewswire Inc.Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare InitiativesNASDAQ:FEMYFemasys Inc
03/28/20244:05PMGlobeNewswire Inc.Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
03/21/20249:00AMGlobeNewswire Inc.Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment LandscapeNASDAQ:FEMYFemasys Inc
03/20/20248:15AMGlobeNewswire Inc.Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of InfertilityNASDAQ:FEMYFemasys Inc
03/13/20249:00AMGlobeNewswire Inc.Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024NASDAQ:FEMYFemasys Inc
03/06/20249:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
03/06/20249:00AMGlobeNewswire Inc.Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility SolutionNASDAQ:FEMYFemasys Inc
02/28/20249:16AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
02/13/20249:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
02/13/20249:44PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
02/06/20248:47AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
02/02/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
02/02/20244:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
02/02/20244:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
12/11/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FEMYFemasys Inc
12/08/20239:28AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FEMYFemasys Inc
11/30/20235:17PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FEMYFemasys Inc
11/29/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
11/22/20234:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
11/22/20234:33PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
11/22/20234:12PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:FEMYFemasys Inc
11/21/20235:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
11/15/20235:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
11/15/20238:30AMBusiness WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.NASDAQ:FEMYFemasys Inc
 Showing the most relevant articles for your search:NASDAQ:FEMY